Clinical approach to adults

Seminars in Nephrology

Volumn 16, Issue 5, 1996, Pages 375-388

  Monk, Rebeca D ^a,b  

^a STRONG MEMORIAL HOSPITAL   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; CALCIUM OXALATE; CALCIUM PHOSPHATE; CYSTINE; STRUVITE; THIAZIDE DIURETIC AGENT; URIC ACID;

ADULT; CALCIUM OXALATE STONE; CLINICAL EXAMINATION; DIET THERAPY; DISEASE PREDISPOSITION; HUMAN; KIDNEY COLIC; LABORATORY DIAGNOSIS; NEPHROLITHIASIS; PRIORITY JOURNAL; REVIEW; STONE ANALYSIS; URIC ACID STONE;

ADULT; HUMANS; INCIDENCE; KIDNEY CALCULI; PROGNOSIS; RISK FACTORS;

EID: 0029745698     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Pak CYC: Pathophysiology of calcium nephrolithiasis, in Seldin DW, Giebisch G (eds): The Kidney: Physiology and Pathophysiology. New York, NY, Raven Press, 1992, pp 2461-2480
2. Concensus Conference: Prevention and treatment of kidney stones. JAMA 260:977-981, 1988
3. Coe FL, Parks JH, Asplin JR: The pathogenesis and treatment of kidney stones. N Engl J Med 327:1141-1152, 1992
4. Asplin J, Chandhoke PS: The stone-forming patient, in Coe FL, Favus MJ, Pak CYC, et al (eds): Kidney Stones: Medical and Surgical Management. Philadelphia, PA, Lippincott-Raven, 1996, pp 337-352
5. Uribarri J, Oh MS, Carroll HJ: The first kidney stone. Kidney Int 111:1006-1009, 1989
6. Millman S, Strauss AL, Parks JH, et al: Pathogenesis and clinical course of mixed calcium oxalate and uric acid nephrolithiasis. Kidney Int 22:366-370, 1982
7. Bushinsky DA: Renal lithiasis, in Kelley WN (ed): Kelley's Textbook of Internal Medicine. Philadelphia, PA, JB Lippincott (in press)
8. Coe FL: Uric acid and calcium oxalate nephrolithiasis. Kidney Int 24:392-403, 1983
9. Mandel G, Mandel N: Analysis of stones, in Coe FL, Favus MJ, Pak CYC, et al (eds): Kidney Stones: Medical and Surgical Management. Philadelphia, PA, Lippincott-Raven, 1996, pp 323-335
10. Monk RD, Bushinsky DA: Pathogenesis of idiopathic hypercalciuria, in Coe FL, Favus MJ, Pak CYC, et al (eds): Kidney Stones: Medical and Surgical Management. Philadelphia, PA, Lippincott-Raven, 1996, pp 759-772
11. Smith LH: Hyperoxaluric states, in Coe FL, Favus MJ (eds): Disorders of Bone and Mineral Metabolism. New York, NY, Raven, 1992, pp 707-727
12. Wainer L, Resnick VA, Resnick MI: Nutritional aspects of stone disease, in Pak CYC (ed): Renal Stone Disease: Pathogenesis, Prevention, and treatment. Boston, MA, Martinus-Nijhoff, 1987, pp 85-120
13. Preminger G, Harvey JA: Diagnostic considerations, in Pak CYC (ed): Renal Stone Disease: Pathogenesis, Prevention, and Treatment. Boston, MA, Martinus Nijhoff, 1987, pp 143-164
14. Worcester EM: Stones due to bowel disease, in Coe FL, Favus MJ, Pak CYC, et al (eds): Kidney Stones: Medical and Surgical Management. Philadelphia, PA, Lippincott-Raven, 1996, pp 883-903
15. Danpure CJ, Smith LH: The primary hyperoxalurias, in Coe FL, Favus MJ, Pak CYC, et al (eds): Kidney Stones: Medical and Surgical Management. Philadelphia, PA, Lippincott-Raven, 1996, pp 859-881
16. Finlayson B: Physical chemical aspects of urolithiasis. Kidney Int 13:344-360, 1978
17. Pak CYC, Holt K, Britton F, et al: Assessment of pathogenetic roles of uric acid, monopotassium urate, monoammonium urate and monosodium urate in hyperuricosuric calcium oxalate nephrolithiasis. Miner Electrolyte Metab 4:130-136, 1980
18. Parks JH, Coe FL: A urinary calcium-citrate index for the evaluation of nephrolithiasis. Kidney Int 30:85-90, 1986
19. Bleyer A, Agus ZS: Approach to nephrolithiasis. The Kidney (published by the NKF) 25:1-10, 1992
20. Breslau NA, Sakhaee K: Pathophysiology of nonhypercalciuric causes of stones, in Pak CYC (ed): Renal Stone Disease: Pathogenesis, Prevention, and Treatment. Boston, MA, Martinus-Nijhoff, 1987, pp 47-84
21. Preminger G, Sakhaee K, Skurla C, et al: Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis. J Urol 134:20-23, 1985
22. Bushinsky DA: The contribution of acidosis to renal osteodystrophy. Kidney Int 47:1816-1832, 1995
23. Bushinsky DA: Net calcium efflux from live bone during chronic metabolic, but not respiratory acidosis. Am J Physiol 256:F836-F842, 1989
24. Lemann J Jr, Litzow JR, Lennon EJ: Studies of the mechanism by which chronic metabolic acidosis augments urinary calcium excretion in man. J Clin Invest 46:1318-1328, 1967
25. Ramchandani P, Pollack HM: Radiologic evaluation of patients with urolithiasis, in Coe FL, Favus MJ, Pak CYC, et al (eds): Kidney Stones: Medical and Surgical Management. Philadelphia, PA, Lippincott-Raven, 1996, pp 369-435
26. Pak CYC: Prevention of recurrent nephrolithiasis, in Pak CYC (ed): Renal Stone Disease: Pathogenesis, Prevention, and Treatment. Boston, MA, Martinus Nijhoff, 1987, pp 165-199
27. Rodman JS: Struvite stones, in Pak CYC (ed): Renal Stone Disease: Pathogenesis, Prevention, and Treatment. Boston, MA, Martinus Nijhoff, 1987, pp 225-251
28. Wong HY, Riedl CR, Griffith DP: Medical management and prevention of struvite stones, in Coe FL, Favus MJ, Pak CYC, et al (eds): Kidney Stones: Medical and Surgical Management. Philadelphia, PA, Lippincott-Raven, 1996, pp 941-950
29. Griffith DP: Struvite stones. Kidney Int 13:372-382, 1978
30. Sakhaee K, Sutton RAL: Pathogenesis and medical management of cystinuria, in Coe FL, Favus MJ, Pak CYC, et al (eds): Kidney Stones: Medical and Surgical management. Philadelphia, PA, Lippincott-Raven, 1996, pp 1007-1017
31. Thier SO, Halperin EC: Cystinuria, in Coe FL (ed): Nephrolithiasis. New York, NY, Churchill Livingstone, 1980, pp 208-230
32. Steigbigel RT, Berry P, Mellors J, et al: Efficacy and safety of the HIV protease inhibitor indinavir sulfate (MK 639) at escalating dose. HIV Abstract 3:80, 1996 (abstr)
33. Mehes K, Szelid Z: Autosomal dominant inheritance of hypercalciuria. Eur J Pediatr 133:239-242, 1980
34. Pak CYC, McGuire J, Peterson R, et al: Familial absorptive hypercalciuria in a large kindred. J Urol 126:717-719, 1981
35. Coe FL, Parks JH, Moore ES: Familial idiopathic hypercalciuria. N Engl J Med 300:337-340, 1979
36. SenLee W, Wells RG, Sabbag RV, et al: Cloning and chromosomal location of a human kidney cDNA involved in cystine, dibasic and neutral amino acid transport. J Clin Invest 91:1959-1963, 1993
37. Shuster J, Jenkins A, Logan C, et al: Soft drink consumption and urinary stone recurrence: A randomized prevention trial. J Clin Epidemiol 45:911-916, 1992
38. Brand E, Harris MM, Billon S: Cystinuria: Excretion of a cystine complex which decomposes in the urine with the liberation of free cystine. J Biol Chem 86:315-331, 1930
39. Parks JH, Coe FL, Strauss AL: Calcium nephrolithiasis and medullary sponge kidney in women. N Engl J Med 306:1088-1091, 1982
40. Higashihara E, Nutahara K, Tago K, et al: Medullary sponge kidney and renal acidification defect. Kidney Int 25:453-459, 1984
41. Ekstrom T, Engelfeldt B, Lagergren C, et al: Medullary sponge kidney: A roentgenologic, clinical, histopathologic and biophysical study. Stockholm, Almqvist and Wiksell, 1959
42. O'Neill M, Breslau NA, Pak CYC: Metabolic evaluation of nephrolithiasis in patients with medullary sponge kidney. JAMA 245:1233-1236, 1981
43. Hosking DH, Erickson SB, Van Den Berg CJ, et al: The stone clinic effect in patients with idiopathic calcium urolithiasis. J Urol 130:1115-1118, 1983
44. Bataille P, Achard JM, Fournier A, et al: Diet, vitamin D, and vertebral mineral density in hypercalciuric calcium stone formers. Kidney Int 39:1193-1205, 1991
45. Lemann J Jr: Pathogenesis of idiopathic hypercalciuria and nephrolithiasis, in Coe FL, Favus MJ (eds): Disorders of Bone and Mineral Metabolism. New York, NY, Raven Press, 1992, pp 685-706
46. Licata A, Bou E, Bartter FC, et al: Effects of dietary protein on urinary calcium in normal subjects and in patients with nephrolithiasis. Metabolism 28:895-900, 1979
47. Allen LH, Oddoye EA, Margen S: Protein-induced hypercalciuria: A longer term study. Am J Clin Nutr 32:741-749, 1979
48. Lemann J Jr, Litzow JR, Lennon EJ: The effects of chronic acid loads in normal man: Further evidence for the participation of bone mineral in the defense against chronic metabolic acidosis. J Clin Invest 45:1608-1614, 1966
49. Lemann J Jr: Idiopathic hypercalciuria in nephrolithiasis, in Coe FL, Brenner BM, Stein JH (eds): Contemporary Issues in Nephrology. New York, NY, Churchill Livingstone, 1980, pp 86-135
50. Allen LH, Bartlett RS, Block GD: Reduction of renal calcium reabsorption in man by consumption of dietary protein. J Nutr 109:1345-1350, 1979
51. Muldowney FP, Freaney R, Moloney MF: Importance of dietary sodium in the hypercalciuria syndrome. Kidney Int 22:292-296, 1972
52. Breslau NA, McGuire JL, Zerwekh JE, et al: The role of dietary sodium on renal excretion and intestinal absorption of calcium and on vitamin D metabolism. J Clin Endocrinol Metab 55:369, 1982
53. Lemann J Jr, Worcester EM, Gray RW: Hypercalciuria and stones (Finlayson colloquium on urolithiasis). Am J Kidney Dis 17:386, 1991
54. Coe FL, Favus MJ, Crockett T, et al: Effects of low-calcium diet on urine calcium excretion, parathyroid function and serum 1,25(OH)2D3 levels in patients with idiopathic hypercalciuria and in normal subjects. Am J Med 72:25-32, 1982
55. Jaeger P, Lippuner K, Casez JP, et al: Low bone mass in idiopathic renal stone formers: Magnitude and significance. J Bone Miner Res 9:1525-1532, 1994
56. Velentzas C, Oreopoulos DG, Meema S, et al: Dietary calcium restriction may be good for patients' stones - but not for their bones, in Smith L, Robertson I, Finlayson B (eds): Urolithiasis Clinical and Basic Research. New York, NY, Plenum, 1981, pp 847-854
57. Curhan G, Willett WC, Rimm EB, et al: A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 328:833-838, 1993
58. Lemann J Jr, Pleuss JA, Worcester EM, et al: Urinary oxalate excretion increases with body size and decreases with increasing dietary calcium intake among healthy adults. Kidney Int 49:200-208, 1996
59. Coe FL, Parks JH, Bushinsky DA, et al: Chlorthalidone promotes mineral retention in patients with idiopathic hypercalciuria. Kidney Int 33:1140-1146, 1988
60. Tieder M, Modai D, Samuel R, et al: Hereditary hypophosphatemic rickets with hypercalciuria. N Engl J Med 312:611-617, 1985
61. Watts RWE, Danpure CJ, de Pauw L, et al: Combined liver-kidney and isolated liver transplantations for primary hyperoxaluria type 1. The European experience. Nephrol Dial Transplant 6:502-511, 1991
62. Pak CYC, Fuller C, Sakhaee K, et al: Long-term treatment of calcium oxalate nephrolithiasis with potassium citrate. J Urol 134:11-19, 1985
63. Pak CYC, Fuller C: Idiopathic hypocitraturic calcium oxalate nephrolithiasis successfully treated with potassium citrate. Ann Intern Med 104:33-37, 1986
64. Ettinger B, Tang A, Citron JT, et al: Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med 315:1386-1389, 1986
65. Coe FL, Raisen L: Allopurinol treatment of uric-acid disorders in calcium-stone formers. Lancet 1:129-131, 1973
66. Michaels EK: Surgical management of struvite stones, in Coe FL, Favus MJ, Pak CYC, et al (eds): Kidney stones: Medical and surgical management. Philadelphia, PA, Lippincott-Raven, 1996, pp 951-970
67. Sant OR, Blaivas JG, Meares EM: Hemiacidrin irrigation in the management of struvite calculi: Long-term results. J Urol 130:1048-1050, 1983
68. Griffith DP, Osborne CA: Infection (urease) stones. Miner Electrolyte Metab 13:278-285, 1996
69. Kolb FO, Earll JM, Harper HA: "Disappearance" of cystinuria in a patient treated with prolonged low methionine diet. Metabolism 16:378-381, 1967
70. Pak CYC: Cystine lithiasis, in Resnick MI, Pak CYC (eds): Urolithiasis: A Medical and Surgical Reference. Philadelphia, PA, WB Saunders, 1990, pp 133-143
71. Lieske JC, Coe FL: Urinary inhibitors and renal stone formation, in Coe FL, Favus MJ, Pak CYC, et al (eds): Kidney Stones: Medical and Surgical Management. Philadelphia, PA, Lippincott-Raven, 1996, pp 65-113